Nifty
Sensex
:
:
18633.95
62920.87
35.30 (0.19%)
74.49 (0.12%)

Pharmaceuticals & Drugs - API

Rating :
55/99

BSE: 532488 | NSE: DIVISLAB

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 92,352.54
  • 50.65
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 89,533.66
  • 0.86%
  • 7.23

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.94%
  • 1.38%
  • 9.61%
  • FII
  • DII
  • Others
  • 14.67%
  • 20.00%
  • 2.40%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.37
  • 18.15
  • 18.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.88
  • 25.18
  • 16.31

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.27
  • 27.55
  • 29.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.94
  • 44.53
  • 49.39

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.80
  • 8.73
  • 10.12

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.67
  • 29.69
  • 32.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Var%
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Net Sales
1,950.77
2,518.44
-22.54%
1,707.68
2,493.24
-31.51%
1,854.54
1,987.51
-6.69%
2,254.52
1,960.64
14.99%
Expenses
1,463.18
1,414.02
3.48%
1,299.40
1,396.06
-6.92%
1,233.50
1,169.44
5.48%
1,407.82
1,108.59
26.99%
EBITDA
487.59
1,104.42
-55.85%
408.28
1,097.18
-62.79%
621.04
818.07
-24.08%
846.70
852.05
-0.63%
EBIDTM
24.99%
43.85%
23.91%
44.01%
33.49%
41.16%
37.56%
43.46%
Other Income
66.15
52.39
26.26%
114.25
16.62
587.42%
80.08
19.11
319.05%
88.39
35.97
145.73%
Interest
0.24
0.08
200.00%
0.13
0.23
-43.48%
0.17
0.21
-19.05%
0.13
0.28
-53.57%
Depreciation
87.02
80.99
7.45%
86.77
79.91
8.58%
85.73
77.35
10.83%
83.66
73.26
14.20%
PBT
466.48
1,075.74
-56.64%
435.63
1,033.66
-57.86%
615.22
759.62
-19.01%
851.30
814.48
4.52%
Tax
145.51
181.10
-19.65%
128.83
131.42
-1.97%
121.62
153.16
-20.59%
149.29
257.37
-41.99%
PAT
320.97
894.64
-64.12%
306.80
902.24
-66.00%
493.60
606.46
-18.61%
702.01
557.11
26.01%
PATM
16.45%
35.52%
17.97%
36.19%
26.62%
30.51%
31.14%
28.41%
EPS
12.09
33.70
-64.12%
11.56
33.99
-65.99%
18.59
22.85
-18.64%
26.45
20.99
26.01%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
7,767.51
8,959.83
6,969.40
5,394.42
4,946.26
3,891.49
4,064.34
3,776.36
3,114.94
2,532.14
2,144.84
Net Sales Growth
-13.31%
28.56%
29.20%
9.06%
27.10%
-4.25%
7.63%
21.23%
23.02%
18.06%
 
Cost Of Goods Sold
3,053.72
2,967.14
2,324.08
2,108.54
1,825.22
1,534.06
1,534.00
1,505.32
1,213.24
914.15
798.63
Gross Profit
4,713.79
5,992.69
4,645.32
3,285.88
3,121.04
2,357.43
2,530.34
2,271.04
1,901.70
1,617.99
1,346.21
GP Margin
60.69%
66.88%
66.65%
60.91%
63.10%
60.58%
62.26%
60.14%
61.05%
63.90%
62.77%
Total Expenditure
5,403.90
5,078.72
4,108.34
3,571.21
3,073.24
2,628.74
2,617.20
2,358.04
1,948.69
1,516.76
1,328.87
Power & Fuel Cost
-
392.33
319.15
280.73
248.78
228.73
198.80
180.34
170.82
147.40
131.02
% Of Sales
-
4.38%
4.58%
5.20%
5.03%
5.88%
4.89%
4.78%
5.48%
5.82%
6.11%
Employee Cost
-
946.16
825.76
621.05
542.27
456.06
499.90
361.19
290.42
232.46
197.72
% Of Sales
-
10.56%
11.85%
11.51%
10.96%
11.72%
12.30%
9.56%
9.32%
9.18%
9.22%
Manufacturing Exp.
-
365.92
297.84
258.91
212.96
182.67
169.15
169.42
147.24
121.10
104.85
% Of Sales
-
4.08%
4.27%
4.80%
4.31%
4.69%
4.16%
4.49%
4.73%
4.78%
4.89%
General & Admin Exp.
-
236.44
175.26
148.62
105.30
139.33
88.22
73.91
63.85
51.74
44.15
% Of Sales
-
2.64%
2.51%
2.76%
2.13%
3.58%
2.17%
1.96%
2.05%
2.04%
2.06%
Selling & Distn. Exp.
-
127.01
124.03
85.36
73.08
64.02
67.48
56.04
51.93
44.22
51.29
% Of Sales
-
1.42%
1.78%
1.58%
1.48%
1.65%
1.66%
1.48%
1.67%
1.75%
2.39%
Miscellaneous Exp.
-
43.72
42.22
68.00
65.63
23.87
59.65
11.80
11.18
5.69
51.29
% Of Sales
-
0.49%
0.61%
1.26%
1.33%
0.61%
1.47%
0.31%
0.36%
0.22%
0.06%
EBITDA
2,363.61
3,881.11
2,861.06
1,823.21
1,873.02
1,262.75
1,447.14
1,418.32
1,166.25
1,015.38
815.97
EBITDA Margin
30.43%
43.32%
41.05%
33.80%
37.87%
32.45%
35.61%
37.56%
37.44%
40.10%
38.04%
Other Income
348.87
115.90
62.67
189.63
155.63
113.44
74.89
97.44
44.70
70.60
44.81
Interest
0.67
2.00
2.10
7.14
4.68
2.37
3.36
4.74
2.88
2.96
2.59
Depreciation
343.18
311.51
255.59
186.24
168.90
142.49
123.33
118.18
136.00
92.12
76.95
PBT
2,368.63
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
Tax
545.25
723.05
681.75
442.92
502.33
354.32
334.92
267.06
220.56
217.58
179.23
Tax Rate
23.02%
19.63%
25.57%
24.34%
27.08%
28.78%
24.00%
19.17%
20.57%
21.96%
22.94%
PAT
1,823.38
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
PAT before Minority Interest
1,823.38
2,960.45
1,984.29
1,376.54
1,352.74
877.01
1,060.42
1,125.78
851.52
773.34
602.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
23.47%
33.04%
28.47%
25.52%
27.35%
22.54%
26.09%
29.81%
27.34%
30.54%
28.07%
PAT Growth
-38.41%
49.19%
44.15%
1.76%
54.24%
-17.30%
-5.81%
32.21%
10.11%
28.46%
 
EPS
68.68
111.50
74.74
51.85
50.95
33.03
39.94
42.40
32.07
29.13
22.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
11,728.18
9,294.61
7,309.92
6,957.15
5,924.80
5,357.39
4,293.31
3,495.36
2,963.35
2,500.60
Share Capital
53.09
53.09
53.09
53.09
53.09
53.09
53.09
26.55
26.55
26.55
Total Reserves
11,675.09
9,241.52
7,256.83
6,904.06
5,871.71
5,304.30
4,240.21
3,468.81
2,936.80
2,474.05
Non-Current Liabilities
436.51
363.94
294.57
991.38
1,768.91
1,411.75
85.17
841.57
650.05
469.75
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.47
1.05
1.55
2.10
Long Term Provisions
26.71
25.42
20.52
772.54
1,577.26
1,288.92
11.57
714.30
533.49
388.43
Current Liabilities
2,454.44
1,728.35
1,820.53
846.75
653.42
659.45
519.50
775.53
627.41
554.45
Trade Payables
795.70
763.20
590.72
492.26
411.21
445.80
232.69
226.87
151.70
160.44
Other Current Liabilities
394.02
340.42
290.09
243.59
175.46
176.63
240.58
203.45
147.80
130.08
Short Term Borrowings
0.00
0.35
33.63
105.60
63.11
35.74
41.42
25.07
16.32
30.51
Short Term Provisions
1,264.72
624.38
906.09
5.30
3.64
1.28
4.81
320.14
311.58
233.42
Total Liabilities
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.98
5,112.46
4,240.81
3,524.80
Net Block
4,325.05
3,703.87
2,781.85
2,087.77
1,996.19
1,559.19
1,438.77
1,308.89
1,221.84
908.72
Gross Block
5,624.27
4,691.86
3,514.25
2,633.93
2,373.45
1,793.95
2,196.08
1,953.02
1,740.34
1,338.35
Accumulated Depreciation
1,299.22
987.99
732.40
546.16
377.26
234.76
757.32
644.13
518.50
429.63
Non Current Assets
5,008.74
4,596.30
3,851.49
4,145.23
3,812.01
3,418.08
1,870.93
2,340.06
1,984.45
1,660.69
Capital Work in Progress
469.93
710.62
919.69
491.91
119.76
443.57
263.91
218.18
144.48
303.41
Non Current Investment
72.01
0.01
0.01
547.26
0.01
0.01
0.01
0.00
0.00
0.00
Long Term Loans & Adv.
133.70
172.59
144.50
1,012.93
1,688.23
1,406.48
162.44
812.63
618.03
448.49
Other Non Current Assets
8.05
9.21
5.44
5.36
7.82
8.83
5.80
0.35
0.09
0.07
Current Assets
9,610.39
6,790.60
5,573.53
4,650.05
4,535.12
4,010.51
3,027.04
2,772.40
2,256.35
1,864.11
Current Investments
0.00
0.00
971.35
1,398.34
1,889.28
1,630.72
802.85
733.00
501.88
407.81
Inventories
2,828.62
2,145.23
1,863.86
1,772.34
1,350.67
1,319.91
1,207.83
1,162.64
932.42
835.69
Sundry Debtors
2,423.88
1,676.52
1,413.35
1,163.37
1,014.36
900.92
880.92
741.64
723.70
512.00
Cash & Bank
2,818.88
2,156.03
122.63
115.26
112.46
78.70
73.43
65.22
40.51
40.89
Other Current Assets
1,539.01
51.95
52.16
142.20
168.35
80.26
62.01
69.89
57.85
67.71
Short Term Loans & Adv.
1,509.32
760.87
1,150.18
58.54
43.37
59.59
42.88
54.98
48.16
57.97
Net Current Assets
7,155.95
5,062.25
3,753.00
3,803.30
3,881.70
3,351.06
2,507.54
1,996.87
1,628.95
1,309.66
Total Assets
14,619.13
11,386.90
9,425.02
8,795.28
8,347.13
7,428.59
4,897.97
5,112.46
4,240.80
3,524.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
1,911.80
1,946.93
1,215.94
954.30
775.86
1,150.37
1,037.86
826.33
556.75
479.97
PBT
3,683.50
2,666.04
1,819.46
1,855.07
1,231.33
1,395.34
1,392.84
1,072.08
990.92
781.24
Adjustment
239.73
189.29
60.01
83.51
32.19
93.87
60.94
91.24
77.55
59.25
Changes in Working Capital
-1,370.45
-264.08
-218.30
-499.84
-219.11
-37.14
-155.03
-125.55
-298.39
-186.05
Cash after chg. in Working capital
2,552.78
2,591.25
1,661.17
1,438.74
1,044.41
1,452.07
1,298.75
1,037.76
770.07
654.44
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-640.98
-644.32
-445.23
-484.44
-268.55
-301.70
-260.89
-211.43
-213.32
-174.47
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,194.92
75.13
-83.47
-685.40
-478.30
-1,139.60
-406.41
-520.84
-305.15
-254.54
Net Fixed Assets
-691.54
-968.33
-1,302.55
-632.52
-255.54
222.19
-288.75
-286.31
-242.98
-368.08
Net Investments
-72.00
971.35
974.24
-56.30
-257.57
-826.05
-77.22
-231.12
-94.07
69.23
Others
-1,431.38
72.11
244.84
3.42
34.81
-535.74
-40.44
-3.41
31.90
44.31
Cash from Financing Activity
-532.44
-34.89
-1,091.42
-245.94
-314.16
2.38
-631.12
-302.95
-248.50
-230.76
Net Cash Inflow / Outflow
-815.56
1,987.17
41.05
22.96
-16.60
13.15
0.33
2.54
3.10
-5.33
Opening Cash & Equivalents
2,030.32
43.15
2.10
-20.86
-4.26
-17.41
17.62
15.09
11.99
17.32
Closing Cash & Equivalent
1,214.76
2,030.32
43.15
2.10
-20.86
-4.26
17.95
17.62
15.09
11.99

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
441.82
350.15
275.38
262.09
223.20
201.82
161.73
131.67
111.63
94.20
ROA
22.77%
19.07%
15.11%
15.78%
11.12%
17.21%
22.49%
18.21%
19.92%
19.17%
ROE
28.16%
23.90%
19.30%
21.00%
15.55%
21.98%
28.91%
26.37%
28.31%
25.99%
ROCE
35.06%
32.07%
25.36%
28.50%
21.68%
28.75%
35.57%
33.06%
36.04%
33.21%
Fixed Asset Turnover
1.74
1.70
1.77
1.98
1.88
2.06
1.83
1.70
1.66
1.78
Receivable days
83.26
80.66
86.18
80.35
89.33
79.19
77.83
85.12
88.42
85.08
Inventory Days
100.99
104.66
121.62
115.23
124.56
112.34
113.70
121.69
126.52
127.96
Payable days
95.88
106.32
93.73
52.21
60.15
47.14
35.06
33.55
36.16
42.47
Cash Conversion Cycle
88.36
79.00
114.07
143.37
153.75
144.39
156.47
173.26
178.78
170.58
Total Debt/Equity
0.00
0.00
0.00
0.02
0.01
0.01
0.01
0.01
0.01
0.01
Interest Cover
1842.75
1270.54
255.83
397.38
520.55
416.28
294.75
373.59
336.24
302.96

News Update:


  • Divi's Laboratories reports 64% fall in Q4 consolidated net profit
    22nd May 2023, 12:44 PM

    Total consolidated income of the company decreased by 21.55% at Rs 2,016.92 crore for Q4FY23

    Read More
  • Divi's Lab - Quarterly Results
    20th May 2023, 13:28 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.